Table 2.
Association between TP53 rs1042522 Polymorphism and Gallbladder Cancer Risk
| Genotype and allele | Number (%) of |
Unadjusted analysis |
Multivariate analysis a |
|||
|---|---|---|---|---|---|---|
| Cases | Controls | OR (95% CI) | P value | OR (95% CI) | P value | |
| GG | 29 (30.2) | 35 (37.6) | 1 | 1 | ||
| CG | 41 (42.7) | 46 (49.5) | 1.08 (0.56-2.06) | 0.83 | 1.09 (0.57-2.10) | 0.80 |
| CC | 26 (27.1) | 12 (12.9) | 2.61 (1.13-6.07) | 0.03 | 2.81 (1.19-6.61) | 0.02 |
| CG + CC | 67 (69.8) | 58 (62.4) | 1.39 (0.76-2.55) | 0.28 | 1.44 (0.78-2.65) | 0.25 |
| PHWE | 0.60 | |||||
| G | 99 (51.6) | 116 (62.4) | 1 | 1 | ||
| C | 93 (48.4) | 70 (37.6) | 1.52 (1.02-2.28) | 0.04 | 1.57 (1.04-2.37) | 0.03 |
*Adjusted for sex and age; OR, odds ratio; CI, confidence interval; PHWE, P value for Hardy-Weinberg equilibrium test among controls; NA, not applicable.